Endologix reported the appointment of Dr. Matthew Thompson, as Chief Executive Officer. Dr. Thompson has been serving as Endologix's Chief Medical Officer since 2016, and, in that capacity, had oversight of the Company's business development, medical affairs, regulatory, clinical, and R&D departments.